physIQ Heart Rhythm and Respiratory Module vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A (physIQ) provides a cloud-based platform for continuous, personalized physiological analytics using data from various wearable biosensors, focusing on detecting subtle changes and early signs of decompensation across cardiac and respiratory systems. Tool B (Verily Study Watch) is a prescription-only wearable device designed for clinical research and healthcare, offering on-demand ECG and irregular pulse monitoring for AFib detection, alongside other physiological and environmental sensor data. While both utilize wearables and cloud analytics for cardiac monitoring, physIQ emphasizes a broader, continuous analytical platform, whereas Verily offers a specific device with integrated advanced sensors primarily for AFib detection and research applications.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if your primary need is continuous, AI-driven personalized physiological monitoring to detect subtle changes and early signs of decompensation in patients. This platform excels at learning individual baselines from wearable biosensor data, offering proactive insights into both cardiac and respiratory health for early intervention.

View physIQ Heart Rhythm and Respiratory Module →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose Verily Study Watch with Irregular Pulse Monitor (Home) if you require a prescription-only wearable for clinical research or targeted healthcare use, specifically for on-demand single-channel ECG and irregular pulse monitoring. Its robust data security, long battery life, and large internal storage make it well-suited for collecting high-integrity physiological data in structured research settings.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature physIQ Heart Rhythm and Respiratory Module Study Watch with Irregular Pulse Monitor (Home)
Pricing Contact for pricing Unknown
Deployment Cloud-based platform Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature physIQ Heart Rhythm and Respiratory Module Study Watch with Irregular Pulse Monitor (Home)
Company physIQ Verily Life Sciences LLC
Description PhysIQ is the leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics. Its industry-leading, enterprise-ready cloud platform continuously collects and processes data from any wearable biosensor using a deep portfolio of FDA-cleared analytics. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Features AI-based personalized physiology analytics, Continuous wearable biosensor data collection, FDA-cleared analytics and digital biomarkers, Learns individual patient baseline, Detects subtle physiological changes and early signs of decompensation, Calculates heart rate and heart rate variability, Detects atrial fibrillation, Determines respiration rate On-demand single-channel ECG measurement, Irregular pulse monitoring for atrial fibrillation (AFib) detection, Multiple physiological sensors (heart rate, electrodermal activity, inertial movements), Environmental sensors, Long battery life (up to one week), Large internal data storage with compression, On-device data encryption for security, Cloud-based data processing with proprietary algorithms and machine learning

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

physIQ's Heart Rhythm and Respiratory Module is designed to continuously collect and process data from any wearable biosensor, offering flexibility in device choice. In contrast, the Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device, the Study Watch itself, which collects its own physiological data.
physIQ's Heart Rhythm and Respiratory Module calculates heart rate, heart rate variability, and respiration rate, detecting subtle changes and early signs of decompensation. The Verily Study Watch monitors heart rate, electrodermal activity, inertial movements, and includes environmental sensors, in addition to ECG and irregular pulse monitoring.
physIQ utilizes continuous wearable biosensor data and FDA-cleared analytics to detect atrial fibrillation. The Verily Study Watch offers irregular pulse monitoring for AFib detection and provides on-demand single-channel ECG measurements.
physIQ's platform features AI-based personalized physiology analytics that learn an individual patient's baseline to detect subtle physiological changes and early signs of decompensation. Verily's Study Watch uses proprietary algorithms and machine learning for cloud-based data processing, but does not explicitly state it learns individual patient baselines in the same way.
physIQ is specialized for Cardiology, Critical Care, and Pulmonology, focusing on continuous remote monitoring and early decompensation detection in adult patients outside of critical care settings. The Verily Study Watch is intended for Cardiology, Family Medicine, and Internal Medicine, primarily for clinical research and prescription use for irregular pulse monitoring in adult patients (22 years and older) who have been diagnosed with, or are susceptible to developing, atrial fibrillation.
AI Tool Finder
AI-powered search. Results may not be comprehensive.